← All organizations

RegeneRx Biopharmaceuticals, Inc.

For profitWebsite ↗

Also known as: ReGenTree, LLC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Nov 15, 2022

Timeline

2000s

Jun 1, 2002
RegeneRx Biopharmaceuticals, Inc.— Founded

Drugs by trial phase (1 distinct, 12 trials)

Phase 3 (1 own, 0 via acquisition)

thymosin beta-4

Indications

Studied for

Recent trials (14)

NCT05555589Lead sponsorPhase 3Nov 15, 2022
NCT03937882Lead sponsorPhase 3May 24, 2019
NCT02974907Lead sponsorPhase 3Nov 1, 2016
NCT01311518Lead sponsorPhase 2Mar 1, 2016
NCT02597803Lead sponsorPhase 2/Phase 3Sep 1, 2015
NCT02600429Lead sponsorPhase 3Sep 1, 2015
NCT01387347Lead sponsorPhase 2Aug 1, 2011
NCT00743769Lead sponsorPhase 1Apr 1, 2008
NCT00598871Study directorPhase 2Dec 1, 2007
NCT00598871Lead sponsorPhase 2Dec 1, 2007
NCT00832091Lead sponsorPhase 2Jul 1, 2006
NCT00382174Lead sponsorPhase 2May 1, 2006
NCT00311766Lead sponsorPhase 2Feb 1, 2006
NCT00311766Study directorPhase 2Feb 1, 2006

Details

Founded: Rockville, MD, US Jun 1, 2002
Last known activity: Nov 15, 2022